FeesSafety
Pluang+

Vail Resorts expects a loss with flat revenue in upcoming Q3 earnings report on Sept 28, 2026.

Company Fundamentals
24 Sep 2026
Tony Dante
View Source
Bearish
Vail Resorts expects a loss with flat revenue in upcoming Q3 earnings report on Sept 28, 2026.

Vail Resorts is set to report its Q3 2026 earnings on September 28, with analysts forecasting a loss per share around -$5.30 and revenue near $271 million, indicating flat performance year-over-year. The company’s financial health shows a high Debt-to-Equity ratio of 5.90 and a current ratio below 1, signaling more debt than equity and slightly more short-term liabilities than assets. Investors will closely watch profitability and revenue trends amid these challenging financial indicators. This report will provide key insights into the company's position in the mountain resort and leisure sector.

Vail Resorts earnings preview provides context for the Consumer Cyclical sector. For readers following this sector, here is Pluang's market snapshot as of Sep 25, 2026 03:01 WIB: Out of 112 priced US stocks, 42 rose and 70 fell. Notable movers include Capri Holdings Ltd (CPRI) up 7.55%, Kohl's Corporation (KSS) down 6.30%, and ThredUp Inc (TDUP) down 6.12%.

More News

Dayton T. Brown opens new Huntsville Test & Qualification Center to boost aerospace and defense testing.

Dayton T. Brown opens new Huntsville Test & Qualification Center to boost aerospace and defense testing.

Dayton T. Brown, Inc. inaugurated its new 104,000-square-foot Test & Qualification Center in Huntsville, Alabama, enhancing its capacity to support aerospace, defense, and propulsion programs. The facility's strategic location near Huntsville's aeros...

Market News
Bullish
1 hour ago
60% of CCOs say communications functions lag behind their leadership roles, needing better systems and resources.

60% of CCOs say communications functions lag behind their leadership roles, needing better systems and resources.

A new study by The Grossman Group reveals that while 60% of chief communications officers (CCOs) have influence at the leadership level, their communications functions lack the necessary systems, skills, and AI capabilities to fully meet their mandat...

Others
Neutral
1 hour ago
Over 200 companies advance 240+ Alzheimer's drugs, marking a new phase in treatment development

Over 200 companies advance 240+ Alzheimer's drugs, marking a new phase in treatment development

More than 200 companies are actively developing over 240 Alzheimer's disease therapies, with around 20 drugs in late-stage trials and many others in earlier phases. Key players include Eli Lilly, Biogen, Johnson & Johnson, and Eisai, focusing on inno...

Market News
Bullish
1 hour ago
Sagimet Biosciences starts key Phase 3 trial for acne drug denifanstat in the U.S.

Sagimet Biosciences starts key Phase 3 trial for acne drug denifanstat in the U.S.

Sagimet Biosciences has initiated a crucial Phase 3 clinical trial in the U.S. for denifanstat, an oral treatment targeting moderate to severe acne. The trial, named AURORA, aims to enroll around 800 patients, including adolescents, to support regula...

Market News
Bullish
1 hour ago
Nokia beats Q3 earnings and revenue estimates with strong AI and cloud sales growth.

Nokia beats Q3 earnings and revenue estimates with strong AI and cloud sales growth.

Nokia reported third-quarter 2026 earnings per share of $0.10, surpassing the $0.08 estimate, and revenue of $5.78 billion, exceeding the $5.72 billion forecast. The company's AI and cloud sales surged 123%, driven by high demand for its IP Networks ...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App